BNP Paribas Financial Markets’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64.4M | Sell |
2,643,121
-148,451
| -5% | -$3.61M | 0.04% | 361 |
|
|
2025
Q1 | $58M | Buy |
2,791,572
+1,253,081
| +81% | +$26M | 0.03% | 412 |
|
|
2024
Q4 | $36.2M | Sell |
1,538,491
-1,742,242
| -53% | -$41M | 0.02% | 557 |
|
|
2024
Q3 | $84M | Buy |
3,280,733
+1,021,498
| +45% | +$26.2M | 0.06% | 242 |
|
|
2024
Q2 | $53M | Sell |
2,259,235
-71,338
| -3% | -$1.68M | 0.04% | 313 |
|
|
2024
Q1 | $67M | Buy |
2,330,573
+1,173,872
| +101% | +$33.8M | 0.06% | 263 |
|
|
2023
Q4 | $38M | Buy |
1,156,701
+612,712
| +113% | +$20.1M | 0.04% | 310 |
|
|
2023
Q3 | $15.2M | Sell |
543,989
-1,154,920
| -68% | -$32.2M | 0.02% | 492 |
|
|
2023
Q2 | $57.9M | Sell |
1,698,909
-284,991
| -14% | -$9.72M | 0.07% | 181 |
|
|
2023
Q1 | $59.7M | Buy |
1,983,900
+1,280,246
| +182% | +$38.5M | 0.08% | 171 |
|
|
2022
Q4 | $19.9M | Sell |
703,654
-1,543,013
| -69% | -$43.6M | 0.03% | 444 |
|
|
2022
Q3 | $73.8M | Buy |
2,246,667
+1,613,999
| +255% | +$53.1M | 0.12% | 92 |
|
|
2022
Q2 | $19.9M | Buy |
632,668
+132,756
| +27% | +$4.18M | 0.03% | 400 |
|
|
2022
Q1 | $23M | Sell |
499,912
-141,551
| -22% | -$6.5M | 0.03% | 382 |
|
|
2021
Q4 | $39.3M | Buy |
641,463
+543,093
| +552% | +$33.3M | 0.06% | 217 |
|
|
2021
Q3 | $7.35M | Buy |
98,370
+18,541
| +23% | +$1.39M | 0.01% | 770 |
|
|
2021
Q2 | $7.38M | Sell |
79,829
-7,610
| -9% | -$704K | 0.01% | 807 |
|
|
2021
Q1 | $7.76M | Buy |
87,439
+61,541
| +238% | +$5.46M | 0.01% | 686 |
|
|
2020
Q4 | $2.42M | Buy |
25,898
+25,663
| +10,920% | +$2.39M | ﹤0.01% | 1063 |
|
|
2020
Q3 | $15K | Buy |
+235
| New | +$15K | ﹤0.01% | 3275 |
|